Sleep Treatment Education Program for Cancer Survivors: STEP-Together

Description

This single-arm research study of off-treatment cancer survivors with self-reported symptoms of insomnia will test the Sleep Treatment Education Program Together (STEP-Together) intervention which is delivered as a synchronous group session by videoconference.

Conditions

Insomnia, Insomnia Chronic, Survivorship

Talk to us

Study Overview

On this page

Study Details

Study overview

This single-arm research study of off-treatment cancer survivors with self-reported symptoms of insomnia will test the Sleep Treatment Education Program Together (STEP-Together) intervention which is delivered as a synchronous group session by videoconference.

Sleep Treatment Education Program Together (STEP-Together): An Online Group Educational Intervention for Insomnia in Cancer Survivors

Sleep Treatment Education Program for Cancer Survivors: STEP-Together

Condition
Insomnia
Intervention / Treatment

-

Contacts and Locations

Boston

Dana Farber Cancer Institute, Boston, Massachusetts, United States, 02115

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Age 18-89
  • * History of a cancer diagnosis (except non-melanoma skin cancer) ≥ 6 months prior
  • * No active cancer therapy (excluding chemoprevention) in the past four months, and no further therapy planned.
  • * Significant insomnia as evidenced by an Insomnia Severity Index score ≥ 8
  • * Regular access to the internet
  • * Able to read and write in English
  • * Usual bedtime does not fall between 5:00 pm and 5:00 am.
  • * Employment in a position where falling asleep at work could impact public safety (such as air traffic-controller, operating heavy machinery).
  • * Ever diagnosed with Bipolar Disorder or with Seizure Disorder, currently taking medications to prevent a seizure, or have experienced a seizure in the prior 12 months.
  • * Any impairment (e.g., hearing, visual, cognitive) that interferes with the ability to complete all study procedures independently.

Ages Eligible for Study

18 Years to 89 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Dana-Farber Cancer Institute,

Christopher Recklitis, PhD, MPH, PRINCIPAL_INVESTIGATOR, Dana-Farber Cancer Institute

Study Record Dates

2026-12-31